ATLAS News · Companies
Forbes Middle East reports Moderna CEO Stéphane Bancel is donating $355M in stock options to undisclosed charitable causes, citing his Jesuit background.
Forbes Middle East reports that Moderna CEO Stéphane Bancel is donating stock options valued at $355M to charitable causes that have not been disclosed.
According to the outlet, Bancel wrote that his Jesuit background motivated the planned donations. He said it instilled in him the idea of servant leadership, or existing to serve a greater good.
Separately, TIKR.com reports that Moderna shares fell 12% over a week and that Bancel wants an FDA filing before the end of the year. The sources do not say what the filing covers.
Stock options give holders the right to buy company shares at a set price, and executives often receive them as part of their pay.
The donation and the filing goal both concern Moderna's leadership and direction, which investors who follow MRNA may take into account.
Price changes are shown for the trading day of the story and are a coincidence in time, not proof that the news caused them. Figures are ATLAS data from our database.
Healthcare · NASDAQ
live price · USD
Closing prices, fair value and probabilities: ATLAS own data. How we calculate fair value.
ATLAS writes its own summaries from the reporting of these outlets. Each link opens the original publisher.
Fair value, probabilities and earnings for every stock. Free account, no card. Information, not advice.
Information, not advice. This content is informational and is not an investment recommendation or an offer to buy or sell securities. ATLAS estimates come from statistical models using public data, can be wrong, and past performance does not guarantee future results. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy
ATLAS